Homepage

Stories / Global Impact

A novel therapy may free some transplant patients from having to take immunosuppressant drugs for...

Stories / Hope

Heart failure affects 26 million people worldwide. Half die within five years of diagnosis. There's...

Stories / Global Impact

Novartis worked with doctors, patients and government officials in the Yaroslavl region of Russia to...

Explore Novartis

Recent Updates

Featured / 20 Aug

Novartis recognized for innovative social business ventures

Novartis ranks #9 on Fortune magazine’s “Change the World” list of companies that are doing well by doing good. 

Our Business

Novartis focuses its business on three leading divisions with strong innovation power and global scale: pharmaceuticals, eye care and generics.